Classer les publications sur l'année
-
Économie de la santé
Aspects économiques du diabète en France : quelles évolutions?
DETOURNAY B
Med Mal Metab ; 2013;7(3):224-227
-
Pharmaco-Epidémiologie
Use of vildagliptin in management of type 2 diabetes : effectiveness, treatment persistence and safety from the 2-year real-life VILDA study
SIMON D, DETOURNAY B, ESCHWEGE E, BOUEE S, BRINGER J, ATTALI C, DEJAGER S
Diabetes Ther ; 2014;5(1):207-224
-
Pharmaco-Epidémiologie
Types 2 diabetes prevalence, health status and quality of care among the North African immigrant population living in France
FOSSE-EDORH S, FAGOT-CAMPANA A, DETOURNAY B, BIHAN H, GAUTIER A, DALICHAMPT M, DRUET C
Diabetes Metab ; 2014;40(2):143-50
-
Pharmaco-Epidémiologie
Management of focal epilepsy in adults treated with polytherapy in France : The direct cost of drug resistance (ESPERA study)
DE ZÉLICOURT M, DE TOFFOL B, VESPIGNANI H, LAURENDEAU C, LÉVY-BACHELOT L, MURAT C, FAGNANI F
Seizure ; 2014;23(5):349-356
-
Économie de la santé
L’évaluation économique dans le champ de la santé
DETOURNAY B
Médecine/Sciences ; 2014;30(5):584-587
-
Pharmaco-Epidémiologie
Adjustment disorder with anxiety in old age: Comparing prevalence and clinical management in primary care and mental health care
ARBUS C, HERGUETA T, DUBURCQ A, SALEH A, LE GUERN M-E, ROBERT P, CAMUS V
Eur Psychiatry ; 2014;29:233-238
-
Pharmaco-Epidémiologie
[Adult patients treated for focal epilepsy with antiepileptic drugs (AEDs) in combination in France: Description according to the 2009 ILAE definition of AED resistance (ESPERA study)]
VESPIGNANI H, DE ZÉLICOURT M, LAURENDEAU C, FAGNANI F, LEVY-BACHELOT L, MURAT C, KAHANE P, DE TOFFOL B
Rev Neurol ; 2014;170(2): 100-109
